Tianshui Zhongxing stock sees abnormal trading volatility

Tianshui Zhongxing Bio-Technology Co. (002772) exhibited abnormal trading volatility, with its closing price showing a cumulative deviation of over 20% across three trading days: September 10, 11, and 12, 2025. The company stated there are no uncorrected disclosures, nor has it found any recent public media reports that could significantly impact its stock price. Furthermore, the company's operational status and internal production activities remain normal, with no material changes in its business or external operating environment.

Neither the company, its controlling shareholder, nor its de facto controller have any unannounced major matters or major matters in the planning stage that should have been disclosed. The controlling shareholder and de facto controller also did not buy or sell company shares during the period of abnormal stock trading.

The company's half-year report for 2025, disclosed on August 16, 2025, showed a slight revenue decline alongside significant profit growth. For the first half of 2025, the company achieved operating revenue of CNY 907,845,326.28, a year-on-year decrease of 0.75%. Net profit attributable to shareholders of listed companies was CNY 69,019,917.47, marking a year-on-year increase of 134.13%.